Looking to Advance New Drugs to the Clinic, UChicago Spinout Pyxis Files for $100M IPO

The University of Chicago spinout Pyxis Oncology has filed for an initial public offering (IPO) after earlier this year signing a worldwide licensing agreement with Pfizer and raising $152 million…

Genes Reveal Details of ‘the Crime,’ Pathway to Develop a Novel Treatment for Neurodegenerative Disease

University of Chicago researcher Christopher Gomez is developing a gene therapy to treat a rare, neurodegenerative disease – and conducting a clinical trial, backed by Pfizer and Biogen,…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept